Methotrexate Scarcity Among Children’s Oncology Group Institutions: Results of a Multinational Survey
The Oncologist · 2025
DOI: 10.1093/oncolo/oyad323 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, 2025. Verfasst von Sarah Menig und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Seattle Children's Hospital, Seattle, WA, USA. Hauptthemen laut MEDLINE: Methotrexate, Neoplasms, Antimetabolites, Antineoplastic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Clinical Trials Network (NCTN).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Shortages of curative chemotherapy agents for children and adults with cancer are ubiquitous. These shortages directly result in compromised outcomes, increased medication errors, heightened cost to health systems, and patient deaths. Methotrexate is a staple of many curative childhood cancer regimens and is frequently in scarcity. No national guidance to manage methotrexate and other chemotherapy shortages exists. To assess the effect of the current methotrexate shortage, a multinational survey of Children’s Oncology Group (COG) member institutions was conducted. Wide variation in the scope of methotrexate shortage in the US was demonstrated; some centers experienced significant scarcity while others experienced no shortage. Methotrexate mitigation strategies differed by COG site, resulting in potential to exacerbate differential access to life-saving medication and inequities in care. Preventing chemotherapy shortages remains a challenge. In the interim, standard guidance to assist clinicians to equitably and fairly cope with methotrexate and related drug shortages is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Seattle Children's Hospital, Seattle, WA, USA.
- Children's Oncology Group, Monrovia, CA, USA.
- Department of Pharmacy, University of Mississippi Medical Center, Children's of Mississippi, Jackson, MS, USA.
- Division of Pharmaceutical Services, Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
- Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA.
- Department of Pediatrics, University of Washington, Seattle, WA, USA.
ORCID-Profile: Yoram Unguru
Förderung
- NCI NIH HHS
- National Clinical Trials Network (NCTN)
Zitieren
APA
Menig, S., Militano, O., Ostrenga, A., Bernhardt, M. B., Lee, B., & Unguru, Y. (2025). Methotrexate Scarcity Among Children’s Oncology Group Institutions: Results of a Multinational Survey. The Oncologist. https://doi.org/10.1093/oncolo/oyad323
Vancouver
Menig S, Militano O, Ostrenga A, Bernhardt MB, Lee B, Unguru Y. Methotrexate Scarcity Among Children’s Oncology Group Institutions: Results of a Multinational Survey. The Oncologist. 2025. doi:10.1093/oncolo/oyad323
BibTeX
@article{Menig2025,
author = {Menig, Sarah and Militano, Olga and Ostrenga, Andrew and Bernhardt, M Brooke and Lee, Brittany and Unguru, Yoram},
title = {Methotrexate Scarcity Among Children’s Oncology Group Institutions: Results of a Multinational Survey},
journal = {The Oncologist},
year = {2025},
doi = {10.1093/oncolo/oyad323}
}
EUVIMED